Consortium invests SEK 7.25m in Antrad Medical

STING provided SEK 1.5m of the funding. The investors believe that Antrad has developed a product that serves a market need and that the company is near its commercialisation stage. Funding will support the company in preparing for its product's market launch.

Company
Antrad Medical is based in Huddinge, near Stockholm, and is a medical equipment producer developing a device for rapid thawing and warming of blood plasma. Current methods of warming blood plasma involve using warm water and can take between 25-40 minutes. Antrad's device reduces this time to five minutes. The company was established in 2008 and is based on research by Lars Ekemar.

People
Martin Gemvik is investment manager at STING Capital.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Nordics
• Healthcare
• Early-stage
• Sweden